ALOCRIL (Allergan, Inc.)
Welcome to the PulseAid listing for the ALOCRIL drug offered from Allergan, Inc.. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | nedocromil sodium |
| SUBSTANCE NAME: | NEDOCROMIL SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-02-03 |
| END MARKETING DATE: | 0000-00-00 |
ALOCRIL HUMAN PRESCRIPTION DRUG Details:
| Item Description | ALOCRIL from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2000-02-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-8842_2f35a2aa-54f1-4abb-b1be-056b17a0d3c5 |
| PRODUCT NDC: | 0023-8842 |
| APPLICATION NUMBER: | NDA021009 |
Other NEDOCROMIL SODIUM Pharmaceutical Manufacturers / Labelers:
